Pharmacology & ToxicologyVirusesPeer-reviewed
Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead
N. G. R. Dayan Elshan, Karen C. Wolff, Frank O. Weiss…·Arnab K. Chatterjee
This paper describes the development of orally bioavailable SARS-CoV-2 protease inhibitors with a hydroxymethyl ketone warhead, showing improved potency and bioavailability compared to previous compounds.
1 citationtop 5%